olpasiran
amgen
['ocean', 'olpasiran']
the sirna olpasiran reduces lp(a) levels in patients with ascvd, according to results from ocean(a)-dose presented at #aha22. researcher calls the effect "dramatic," with some patients seeing reductions of 100%.
read more from : 
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions, plus #COVID19 and the heart. Register at https://t.co/9j3KOizL9o